| Literature DB >> 29106031 |
Takeshi Fujiwara1,2, Satoshi Hoshide1, Yuichiro Yano3, Hiroshi Kanegae4, Kazuomi Kario1.
Abstract
The aim of this study was to compare the effect of morning and bedtime administration of valsartan/amlodipine combination therapy (80/5 mg) on nocturnal brachial and central blood pressure (BP) measured by ambulatory BP monitoring in patients with hypertension. This was a 16-week prospective, multicenter, randomized, open-label, crossover, noninferiority clinical trial. Patients underwent 24-hour ambulatory BP monitoring at randomization, at switching, and at the end of the study. Twenty-three patients (mean age, 68.0 years) were studied. The difference in nocturnal brachial systolic BP between the morning and bedtime administrations of combination valsartan/amlodipine was -3.2 mm Hg, and the two-sided 95% confidence interval ranged from -6.8 to 0.4 mm Hg. The difference in nocturnal central systolic BP was -4.0 mm Hg (95% confidence interval, -7.6 to -0.4 mm Hg). The upper limit of the 95% confidence interval was below the margin of 3.0 mm Hg in both nocturnal brachial and central systolic BP, confirming the noninferiority of morning administration to the bedtime administration of valsartan/amlodipine combination therapy. ©2017 Wiley Periodicals, Inc.Entities:
Keywords: amlodipine; bedtime administration; clinical trial; crossover; morning administration; nocturnal central blood pressure; noninferiority; valsartan
Mesh:
Substances:
Year: 2017 PMID: 29106031 PMCID: PMC8030911 DOI: 10.1111/jch.13128
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738